You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR LANTHANUM CARBONATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LANTHANUM CARBONATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00150540 ↗ A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol. Completed Shire Phase 3 2002-10-14 The purpose of this study is to assess the safety of lanthanum carbonate in patients undergoing dialysis who have received lanthanum carbonate in the previous studies and wish to continue treatment.
NCT00150566 ↗ Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood Completed Shire Phase 3 2004-02-09 The purpose of this study is to test how well higher doses of lanthanum carbonate reduce the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease.
NCT00151918 ↗ Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease Completed Shire Phase 3 2005-01-07 The purpose of this study is to assess phosphate reduction and control in patients with End Stage Renal Disease treated with either lanthanum carbonate or sevelamer hydrochloride
NCT00151931 ↗ Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis Completed Shire Phase 3 2004-05-11 The purpose of this study is to assess phosphate reduction and control in patients with End Stage Renal Disease treated with lanthanum carbonate
NCT00160121 ↗ Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease Completed Shire Phase 4 2005-01-10 The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the patient and physician's satisfaction.
NCT00234702 ↗ Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease Completed Shire Phase 2 2006-01-11 Chronic kidney disease (CKD) can result in a loss of ability to filter and excrete phosphate. The body's attempt to adjust to an increased level of phosphate in the blood can result in elevated levels of hormones and minerals resulting in serious clinical consequences. This study is being conducted to evaluate the safety and efficacy of lanthanum carbonate in lowering high levels of phosphorus in the blood in subjects with CKD Stages 3 and 4 compared to placebo.
NCT00438932 ↗ Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease Completed Shire N/A 2007-01-01 The purpose of this study is to learn more about how the kidneys control the blood levels of phosphorus in patients with early chronic kidney disease. The ultimate goal is to use this information to design improved treatment strategies for phosphorus-related problems for the millions of patients with chronic kidney disease.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LANTHANUM CARBONATE

Condition Name

Condition Name for LANTHANUM CARBONATE
Intervention Trials
Hyperphosphatemia 12
Chronic Kidney Disease 9
Kidney Failure, Chronic 6
Kidney Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LANTHANUM CARBONATE
Intervention Trials
Kidney Diseases 27
Renal Insufficiency, Chronic 22
Hyperphosphatemia 14
Kidney Failure, Chronic 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LANTHANUM CARBONATE

Trials by Country

Trials by Country for LANTHANUM CARBONATE
Location Trials
United States 80
Japan 50
Germany 11
Australia 6
South Africa 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LANTHANUM CARBONATE
Location Trials
California 9
Illinois 7
Colorado 7
Tennessee 4
Florida 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LANTHANUM CARBONATE

Clinical Trial Phase

Clinical Trial Phase for LANTHANUM CARBONATE
Clinical Trial Phase Trials
Phase 4 6
Phase 3 13
Phase 2 7
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LANTHANUM CARBONATE
Clinical Trial Phase Trials
Completed 34
Unknown status 4
Terminated 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LANTHANUM CARBONATE

Sponsor Name

Sponsor Name for LANTHANUM CARBONATE
Sponsor Trials
Shire 25
Bayer 8
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LANTHANUM CARBONATE
Sponsor Trials
Industry 41
Other 22
NIH 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.